Yingying Hu

Title: Yingying Hu: Innovator in IL-2 Mutants

Introduction

Yingying Hu is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of IL-2 mutants. With a total of 3 patents to her name, her work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

Yingying Hu's latest patents focus on IL-2 mutants and their applications. The disclosures detail the development of IL-2 mutants, corresponding fusion proteins, conjugates, nucleic acid fragments, vectors, and host cells. These innovations include methods for preparing the mutants or fusion proteins, as well as pharmaceutical compositions and uses. Notably, the IL-2 mutants exhibit higher Tm values and improved stability compared to wild-type IL-2. Additionally, these mutants may have increased yield or altered binding activity to the IL-2Rβγ complexes, enhancing their therapeutic potential.

Career Highlights

Throughout her career, Yingying Hu has worked with notable companies such as Hainan Simcere Pharmaceutical Co., Ltd. and Jiangsu Huaiyu Pharmaceutical Co., Ltd. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations.

Collaborations

Yingying Hu has collaborated with esteemed colleagues, including Zhuoxiao Cao and Renhong Tang. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in her field.

Conclusion

Yingying Hu is a distinguished inventor whose work on IL-2 mutants showcases her commitment to advancing pharmaceutical science. Her contributions have the potential to lead to significant improvements in disease treatment and patient care.